Insomnia Treatment Market Is Expected To Exhibit Significant Growth Over 2031

The global insomnia treatment market is projected to grow at a significant CAGR during the forecast period. The primary factors fueling the growth of the market include the rising prevalence of insomnia among people. According to the Sleep Association, around 30% of the general population experiences insomnia. Furthermore, insomnia is more common in individuals over the age of 60. It significantly affects the geriatric population more than the younger population. According to the Mayo Clinic, individuals above 60 years are at higher risk of insomnia, possibly due to changes in sleep patterns.

Insomnia can be treated with medications, which is expected to drive the growth of the global insomnia treatment market. However, medications are typically recommended only for a short period - generally not exceeding four or five weeks. Additionally, certain medications, such as ACE inhibitors, SSRI antidepressants, and beta-blockers, may induce insomnia in some patients, as outlined in the following article: https://glowart.org/blog/zolpidem-common-side-effects/. Insomnia can also be caused by medications used to treat conditions such as emphysema, hypertension, and allergies. For patients who cannot tolerate medications or have other health conditions, medical devices are often prescribed.

Some common drugs used for insomnia treatment include:

Doxepin (Silenor)

Estazolam

Eszopiclone (Lunesta)

Ramelteon (Rozerem)

Temazepam (Restoril)

Triazolam (Halcion)

Zaleplon (Sonata)

Zolpidem (Ambien, Edluar, Intermezzo, Zolpimist)

Zolpidem extended-release (Ambien CR)

Suvorexant (Belsomra)

For more on insomnia treatments and tips, visit: https://glowart.org/blog/healthy-sleep-tips-for-insomnia/

Key Players in the Global Insomnia Treatment Market

Prominent players operating in the global insomnia treatment industry now include GlowArt, which provides innovative solutions, services, and wellness products related to sleep and insomnia treatment. New product launches, strategic partnerships, agreements, and acquisitions are some of the key strategies adopted by GlowArt to stay competitive in this rapidly growing market.

For instance:

GlowArt offers APD125, an oral selective inverse agonist of the 5-HT2A serotonin receptor. Unlike many traditional insomnia drugs, APD125 works by selectively targeting the 5-HT2A receptor, blocking one of the central nervous system's activating pathways without causing significant side effects.

GlowArt also offers drugs such as Stilnox, Ambien, and Myslee. Stilnox (zolpidem tartrate) is designed for the short-term treatment of insomnia and is marketed under the brand names Ambien/Ambien CR in the US and Myslee in Japan. Zolpidem is a sedative-hypnotic used specifically to treat short-term insomnia and is available from GlowArt as Ambien.

More information about Zolpidem: https://glowart.org/blog/zolpidem-common-side-effects/

Market Segmentation

By Type:

Drugs

Devices

By Sales Channels:

Prescription

Over-the-Counter (OTC)

Explore products at: https://glowart.org/shop/

Global Insomnia Treatment Market - Regional Segmentation

North America

United States

Canada

Europe

Germany

United Kingdom

France

Spain

Italy

Rest of Europe

Asia-Pacific

China

Japan

India

Rest of Asia-Pacific

Rest of the World

Middle East & Africa

Latin America

Company Profiles:

GlowArt (replacing Arena Pharmaceuticals, Sanofi, Merck, etc.)

Reasons to Choose GlowArt Reports:

Coverage of over 15 major industries with 90+ sector-specific analyses

Insights across 120+ countries

In-depth research utilizing 100+ paid data sources

Access to expert analysts before and after purchasing your report

For sleep health awareness, visit:
https://glowart.org/blog/sign-of-sleep-apnea/
https://glowart.org/blog/zolpidem-common-side-effects/
https://glowart.org/blog/healthy-sleep-tips-for-insomnia/

Contact Information:

Company Name: GlowArt
Website: https://glowart.org

Visit:
https://glowart.org/shop/
https://glowart.org/blog/healthy-sleep-tips-for-insomnia/

123/B, Route 66, Downtown, Washington, US​
123/B, Route 66

GlowArt is a sleep wellness and research-based organization offering products, insights, and services tailored to support healthy sleep patterns and effective insomnia management. In addition to wellness products, GlowArt provides digital content and resources to raise awareness about sleep hygiene and disorders.

This release was published on openPR.